Authors: Ballinger, MD Shyamala, V Forrest, LD Deuter-Reinhard, M Doyle, LV Wang, JX Panganiban-Lustan, L Stratton, JR Apell, G Winter, JA Doyle, MV Rosenberg, S Kavanaugh, WM

Citation: Md. Ballinger et al., Semirational design of a potent, artificial agonist of fibroblast growth factor receptors, NAT BIOTECH, 17(12), 1999, pp. 1199-1204

Authors: Vollenweider, P Clodi, M Martin, SS Imamura, T Kavanaugh, WM Olefsky, JM

Citation: P. Vollenweider et al., An SH2 domain-containing 5 ' inositolphosphatase inhibits insulin-induced GLUT4 translocation and growth factor-induced actin filament rearrangement, MOL CELL B, 19(2), 1999, pp. 1081-1091

Authors: Wisniewski, D Strife, A Swendeman, S Erdjument-Bromage, H Geromanos, S Kavanaugh, WM Tempst, P Clarkson, B

Citation: D. Wisniewski et al., A novel SH2-Containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells, BLOOD, 93(8), 1999, pp. 2707-2720

Authors: Shyamala, V Khoja, H Anderson, ML Wang, JX Cen, H Kavanaugh, WM

Citation: V. Shyamala et al., High-throughput screening for ligand-induced c-fos mRNA expression by branched DNA assay in Chinese hamster ovary cells, ANALYT BIOC, 266(1), 1999, pp. 140-147